C2 C Wealth Management, LLC Abb Vie Inc. Transaction History
C2 C Wealth Management, LLC
- $110 Million
- Q2 2025
A detailed history of C2 C Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, C2 C Wealth Management, LLC holds 4,052 shares of ABBV stock, worth $924,666. This represents 0.68% of its overall portfolio holdings.
Number of Shares
4,052
Previous 4,010
1.05%
Holding current value
$924,666
Previous $840,000
10.48%
% of portfolio
0.68%
Previous 0.79%
Shares
12 transactions
Others Institutions Holding ABBV
# of Institutions
4,375Shares Held
1.3BCall Options Held
16.1MPut Options Held
10.9M-
Vanguard Group Inc Valley Forge, PA177MShares$40.5 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$18.3 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$12.5 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.52 Billion0.52% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $403B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...